REFERENCES
1. Camilleri M. Diagnosis and treatment of irritable bowel syndrome: a review. JAMA. 2021;325:865-77.
2. Staudacher HM, Mikocka-Walus A, Ford AC. Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials. Lancet Gastroenterol Hepatol. 2021;6:401-10.
3. Simrén M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62:159-76.
4. Linsalata M, Riezzo G, D’attoma B, Clemente C, Orlando A, Russo F. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study. BMC Gastroenterol. 2018;18:167.
5. Drossman DA, Hasler WL. Rome IV - Functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150:1257-61.
6. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:131-9.
8. Mayer EA, Bradesi S, Chang L, Spiegel BMR, Bueller JA, Naliboff BD. Functional GI disorders: from animal models to drug development. Gut. 2008;57:384-404.
9. Sittipo P, Shim J, Lee Y. Microbial metabolites determine host health and the status of some diseases. Int J Mol Sci. 2019;20:5296.
10. James SC, Fraser K, Young W, Mcnabb WC, Roy NC. Gut microbial metabolites and biochemical pathways involved in irritable bowel syndrome: effects of diet and nutrition on the microbiome. J Nutr. 2020;150:1012-21.
11. Yang W, Tan H, Nie S. A low-FODMAP diet enhances IBS symptom relief and gut microbiota homeostasis: a meta-analysis. Food Bioscience. 2025;71:107190.
12. Valdez-palomares F, Nambo-Venegas R, Uribe-García J, et al. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet. Food Funct. 2021;12:3206-18.
13. Sciavilla P, Strati F, Di Paola M, et al. Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients. Appl Microbiol Biotechnol. 2021;105:3277-88.
14. Choi SI, Kim N, Nam RH, et al. The protective effect of Roseburia faecis against repeated water avoidance stress-induced irritable bowel syndrome in a wister rat model. J Cancer Prev. 2023;28:93-105.
15. Pecyna P, Bykowska-Derda A, Gabryel M, et al. Blautia spp. in the gut microbiome: relation to dietary choices and to the nutritional status of patients with irritable bowel syndrome. Nutrition. 2025;138:112836.
16. Rui W, Li X, Wang L, Tang X, Yang J. Potential applications of Blautia wexlerae in the regulation of host metabolism. Probiotics & Antimicro. Prot. 2024;16:1866-74.
17. Chen J, Zhao T, Li H, et al. Multi-omics analysis of gut microbiota and host transcriptomics reveal dysregulated immune response and metabolism in young adults with irritable bowel syndrome. Int J Mol Sci. 2024;25:3514.
18. Malinen E. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol. 2010;16:4532.
19. Yang J, Wang P, Liu T, et al. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome. BMC Microbiol. 2021;21:316.
20. Xu H, Ma C, Zhao F, et al. Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome. Eur J Nutr. 2020;60:2553-65.
21. Taras D, Simmering R, Collins MD, Lawson PA, Blaut M. Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2002;52:423-8.
22. Duncan SH. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol. 2002;52:2141-6.
23. Simon DW, Rogers MB, Gao Y, et al. Depletion of gut microbiota is associated with improved neurologic outcome following traumatic brain injury. Brain Res. 2020;1747:147056.
24. Bharwani A, Mian MF, Foster JA, Surette MG, Bienenstock J, Forsythe P. Structural & functional consequences of chronic psychosocial stress on the microbiome & host. Psychoneuroendocrinology. 2016;63:217-27.
25. Zhang J, Wang X, Lu Y, Qiao Y, Xia X, Tu J. Microstructure and infrared reflectance modulation properties in DC-sputtered tungsten oxide films. J Solid State Electrochem. 2010;15:2213-9.
26. Chen C, Lu M, Pan Q, et al. Berberine improves intestinal motility and visceral pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms in an opioid-receptor dependent manner. PLoS ONE. 2015;10:e0145556.
27. Furuichi M, Kawaguchi T, Pust M, et al. Commensal consortia decolonize Enterobacteriaceae via ecological control. Nature. 2024;633:878-86.
28. Weiss AS, Burrichter AG, Durai Raj AC, et al. In vitro interaction network of a synthetic gut bacterial community. The ISME Journal. 2022;16:1095-109.
29. Weiss AS, Niedermeier LS, Von Strempel A, et al. Nutritional and host environments determine community ecology and keystone species in a synthetic gut bacterial community. Nat Commun. 2023;14:4780.
30. Yim SK, Kim SW, Lee ST. Efficient stool collection methods for evaluating the diarrhea score in mouse diarrhea models. In Vivo. 2021;35:2115-25.
31. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H. A two-trial memory task with automated recording: study in young and aged rats. Brain Res. 1992;588:132-9.
32. Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015:52434.
33. Zhang S, Nie Q, Sun Y, et al. Bacteroides uniformis degrades β-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. Microbiome. 2024;12:177.
34. Liu C, Zhao D, Ma W, et al. Denitrifying sulfide removal process on high-salinity wastewaters in the presence of Halomonas sp. Appl Microbiol Biotechnol. 2015;100:1421-6.
35. Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884-90.
36. Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27:2957-63.
37. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10:996-8.
38. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261-7.
39. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537-41.
40. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.
41. Barberán A, Bates ST, Casamayor EO, Fierer N. Using network analysis to explore co-occurrence patterns in soil microbial communities. The ISME Journal. 2012;6:343-51.
42. Zhang S, Sun Y, Li Y, Chen C, Nie S. A synbiotic combination of arabinogalactan and Bacteroides thetaiotaomicron ameliorates ulcerative colitis in mice. Food Res Int. 2026;230:118617.
43. Li S, Tan H, Yang J, et al. Effects of three homogalacturonan-type pectins on mice with metabolic syndrome. J Agric Food Chem. 2025;73:13075-88.
44. Hao M, Song J, Zhai X, et al. Improvement of loperamide-hydrochloride-induced intestinal motility disturbance by Platycodon grandiflorum polysaccharides through effects on gut microbes and colonic serotonin. Front. Cell. Infect. Microbiol. 2023;13:1105272.
45. Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359:1151-6.
46. Hosseinkhani F, Dubbelman A, Karu N, Harms AC, Hankemeier T. Towards standards for human fecal sample preparation in targeted and untargeted LC-HRMS studies. Metabolites. 2021;11:364.
47. Luczynski P, Mcvey Neufeld K, Oriach CS, Clarke G, Dinan TG, Cryan JF. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int J Neuropsychopharmacol. 2016;19:pyw020.
48. O’Mahony S, Clarke G, Borre Y, Dinan T, Cryan J. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32-48.
49. Pokusaeva K, Johnson C, Luk B, et al. GABA‐producing Bifidobacterium dentium modulates visceral sensitivity in the intestine. Neurogastroenterology Motil. 2016;29:e12904.
50. Wahlström A, Sayin SI, Marschall H, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41-50.
51. Ackerman HD, Gerhard GS. Bile acids in neurodegenerative disorders. Front. Aging Neurosci. 2016;8.
52. Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160:99-114.e3.
53. Black CJ, Burr NE, Camilleri M, et al. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 2020;69:74-82.
54. Zhang B, Vogelzang A, Miyajima M, et al. B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity. Nature. 2021;599:471-6.
55. Jiang L, Zhu B, Zhao Y, et al. Membralin deficiency dysregulates astrocytic glutamate homeostasis, leading to ALS-like impairment. J Clin Investig. 2019;129:3103-20.
56. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int. 2012;95:50-60.
57. Cotter PD, Ross RP, Hill C. Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol. 2012;11:95-105.
58. Sato Y, Atarashi K, Plichta DR, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021;599:458-64.
59. Canani RB, Di Costanzo M, Leone L, Pedata M, Meli R, et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011;17:1519.
60. Kenny DJ, Plichta DR, Shungin D, et al. Cholesterol metabolism by uncultured human gut bacteria influences host cholesterol level. Cell Host Microbe. 2020;28:245-257.e6.
61. Bai D, Zhao J, Wang R, et al. Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier. Acta Pharmaceutica Sinica B. 2024;14:1677-92.
62. Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2019;11:158-71.
63. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2016;19:29-41.
64. Li W, Zhang L, Chen S. Spinal astrocytes in chronic visceral pain. Dev Neurobiol. 2025;85:e22996.
65. Ikegami M, Narabayashi H, Nakata K, et al. Intervention in gut microbiota increases intestinal γ-aminobutyric acid and alleviates anxiety behavior: a possible mechanism via the action on intestinal epithelial cells. Front. Cell. Infect. Microbiol. 2024;14:1421791.
67. Schlicker E, Kathmann M. Role of the histamine H3 receptor in the central nervous system. In: Hattori Y, Seifert R, Editors. Histamine and histamine receptors in health and disease. Cham: Springer International Publishing; 2016. pp. 277-99.
68. Zampieri G, Efthimiou G, Angione C. Multi-dimensional experimental and computational exploration of metabolism pinpoints complex probiotic interactions. Metab Eng. 2023;76:120-32.
69. Fredua-agyeman M, Stapleton P, Basit AW, Gaisford S. Microcalorimetric evaluation of a multi-strain probiotic: Interspecies inhibition between probiotic strains. J Funct Foods. 2017;36:357-61.
70. Shin AS, Xing Y, Waseem MR, et al. Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS). Sci Rep. 2025;15:35375.
71. Wylensek D, Hitch TCA, Riedel T, et al. A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity. Nat Commun. 2020;11:6389.
72. Zhang Z, Yang Z, Lin S, et al. Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels. Gut Microbes. 2025;17:2520407.
73. Zhang Y, Tu S, Ji X, et al. Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway. Nat Commun. 2024;15:1333.
74. Liu T, Chen M, Zhang C, et al. Hypertension inhibition by Dubosiella newyorkensis via reducing pentosidine synthesis. npj Biofilms Microbiomes. 2025;11:34.
75. Ye X, Sun P, Lao S, et al. Fgf21-Dubosiella axis mediates the protective effects of exercise against NAFLD development. Life Sci. 2023;334:122231.
